×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

InsideArbitrage Event Driven Monitor – January 26, 2024

  • January 26, 2024
Merger Arbitrage RYZB: Bristol-Myers Squibb (BMY) and RayzeBio (RYZB) intend to file on January 25, 2024, a premerger notification and report form under the HSR Act with the Antitrust Division and the FTC. The initial expiration date of the tender offer is February 22, 2024. CSTR: Old National (ONB) and CapStar (CSTR) need to obtain consents including approvals from the Federal Reserve Board and the OCC. IMGN: ImmunoGen (IMGN) and AbbVie (ABBV) filed a notification with respect to the merger with the German Federal Cartel Office (the “FCO”) on January 11, 2024. FNCB: FNCB Bancorp (FNCB) and Peoples Financial Services (PFIS) file their definitive proxy statement and schedule shareholder vote on March 22, 2024. You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here. Deal in the works TELL: According to Bloomberg, Tellurian (TELL) has engaged Lazard to evaluate a potential sale. M: According to the NY Post, Private-equity giant Sycamore Partners is exploring a possible bid to buy Macy’s (M). Sycamore has been in quiet talks with Macy’s since at least late December. Insider Purchases CTBI: Eleven different insiders purchased shares of regional bank Community Trust Bancorp Inc. (CTBI) at the...

Only plus or premium subscribers can access this post. Subscribe today.